Showing results (61-70 of 237) with videos related to
Sort By:
Pageof 24
Trends in Molecular Medicine|April 4, 2016
Reappraisal of GIP Pharmacology for Metabolic DiseasesBrian Finan, Timo D Müller, Christoffer Clemmensen, et al.Cell|February 25, 2017
Gut-Brain Cross-Talk in Metabolic ControlChristoffer Clemmensen, Timo D Müller, Stephen C Woods, et al.Cell Metabolism|August 17, 2023
GIPR/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applicationsJonathan E Campbell, Timo D Müller, Brian Finan, et al.Physiologia Plantarum|July 26, 2024
The enigmatic enzyme 'amidoxime reducing component' of Lotus japonicus. Characterization, expression, activity in plant tissues, and proposed role as a nitric oxide-forming nitrite reductaseSamuel Minguillón, Katrin Fischer-Schrader, Carmen Pérez-Rontomé, et al.Bioorganic & Medicinal Chemistry|June 20, 2015
Discovery of novel, non-acidic mPGES-1 inhibitors by virtual screening with a multistep protocolStefan M Noha, Katrin Fischer, Andreas Koeberle, et al.Plos One|September 13, 2012
Influence of acute exposure to high altitude on basal and postprandial plasma levels of gastroenteropancreatic peptidesRudolf L Riepl, Rainald Fischer, Hubert Hautmann, et al.Structure (London, England : 1993)|October 7, 2003
The crystal structure of plant sulfite oxidase provides insights into sulfite oxidation in plants and animalsNils Schrader, Katrin Fischer, Karsten Theis, et al.Cell Metabolism|July 14, 2016
Unimolecular Polypharmacy for Treatment of Diabetes and ObesityMatthias H Tschöp, Brian Finan, Christoffer Clemmensen, et al.Cell|July 26, 2024
Transforming obesity: The advancement of multi-receptor drugsChristine M Kusminski, Diego Perez-Tilve, Timo D Müller, et al.Diabetologia|July 23, 2017
GLP-1/glucagon receptor co-agonism for treatment of obesityMiguel A Sánchez-Garrido, Sara J Brandt, Christoffer Clemmensen, et al.Pageof 24